Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Non-comparative, Multicenter, Phase III for Evaluation of Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Previously Treated Patients With Hemophilia A

NCT01568580 is registered in ClinicalTrials.gov with Green Cross Corporation as lead sponsor.

NCT NCT01568580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01568580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Non-comparative, Multicenter, Phase III for Evaluation of Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Previously Treated Patients With Hemophilia A
Lead sponsor
Green Cross Corporation
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2004
Completion date
September 30, 2006
Enrollment
71 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a